Boris Minev

Boris Minev, MD, is the Chief Scientific Officer at CureScience Institute, where they focus on immuno-oncology and personalized patient solutions. They are also an Adjunct Professor at Moores UCSD Cancer Center and serve on the Advisory Board of the European Society for Translational Medicine. Previously, Boris held notable roles as Director of Immunotherapy and Translational Oncology at Genelux Corporation and Principal Investigator at Moores UCSD Cancer Center. Boris completed their M.D. at the School of Medicine in Sofia, Bulgaria, and furthered their education with postdoctoral studies at The Weizmann Institute and the National Cancer Institute.